GeoVax's COVID-19 Vaccine Shows Promise for Immunocompromised Patients
September 8, 2025 — GeoVax's GEO-CM04S1 vaccine demonstrates strong immune responses in immunocompromised patients, offering hope for better COVID-19 protection in vulnerable groups.